Gate2Brain as alumni at Caixa Impulse Validate

CaixaImpuls

On Monday 4th of October, Gate2Brain gave a talk at the Caixa Impulse Validate session. An acceleration program that provides support to early-stage biomedical research projects to help them validate their asset and define their valorization plan.

Two years ago, Gate2Brain was at this same session as an early-stage biotech being part of the program. Today, our CEO, Meritxell Teixidó, was invited alumni to explain Gate2Brain’s initial steps in its entrepreneurial journey to bring medicines beyond barriers.

An excellent session of exchange and networking brewing talent and innovative projects.

/by
You might also like
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
BioSpain2021Gate2Brain attending BioSpain 2021
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell”Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Gate2Brain attending BioSpain 2021BioSpain2021Pediatric Innovation Dayi4kidsPediatric Innovation Day